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Abstract
q  q q.The regulation of the furosemide-sensitive Na -ATPase activity and ouabain-sensitive Na qK ATPase activities
from proximal tubules by adenosine was investigated. When the concentration of adenosine was increased the furosemide-
y8  .  qsensitive ATPase activity decreased with maximal inhibition at 10 M 56% of inhibition . However, the Na q
q.K ATPase activity was not affected by adenosine. Theophylline, an antagonist of P adenosine receptor, completely1
reversed the effect of adenosine on the furosemide-sensitive ATPase activity in a dose-response manner. The adenosine
6  . Xeffect was mimicked by N -cyclohexyladenosine CHA , an agonist for A adenosine receptor. 5 -N-ethylcarboxamide-1
 .adenosine NECA , an agonist for A adenosine receptor, did not affect the furosemide-sensitive ATPase activity. When2
adenosine was used in the presence of 1 mg mly1 pertussis toxin, a Gi protein inhibitor, no change in the furosemide-sensi-
tive ATPase activity was observed. The addition of 1 nM cholera toxin increased the Naq-ATPase activity by 60%.
Adenosine decreased the cholera toxin stimulated Naq-ATPase in 42%, similar to the effect observed in the absence of
cholera toxin. Dibutyryl-cAMP reversed the effect of adenosine in a dose dependent manner while the protein kinase A
peptide inhibitor mimicked it. These data are compatible with a modulatory effect of adenosine on the Naq-ATPase activity
via A subtype receptor. q 1997 Elsevier Science B.V.1
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1. Introduction
Adenosine has a crucial role in cellular energy
metabolism and is recognized as a cellular messenger
that produces specific biochemical effects, which re-
sult in physiological response. It has been established
that the effect of adenosine is mediated by interac-
w xtions with receptors 1 . Two types of receptors were
proposed to mediate the adenosine effects: P1
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 . adenosine receptor and P adenosine nucleotide2
. w xreceptors 2,3 . The relative affinities for P sites are1
adenosine )AMP )ADP, while for P sites the2
w xpotencies are ATP )ADP )AMP )adenosine 1 .
P receptors are further subdivided in two principal1
subtypes of receptors: A and A , which can be1 2
differentiated on the basis of their affinities for
adenosine and several adenosine analogues, and their
w xeffects on adenylyl cyclase 1 . The A receptor has1
 .higher affinity for adenosine 0.5–100 nM than the
 . w xA receptor 0.5–25 mM 1 . A receptors are in-2 1
volved with a decrease in adenylyl cyclase activity
mediated by pertussis toxin-sensitive GTP binding
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00121-1
( )C. Caruso-Ne˝es et al.rBiochimica et Biophysica Acta 1329 1997 336–344 337
protein, while A receptors are involved with an2
increase in the adenylyl cyclase activity, mediated by
w xcholera toxin-sensitive GTP binding protein 1,4,5 .
It has been observed that the kidneys produce
adenosine, and in some conditions, such as during
w xischemia, there is an increase in its production 6 .
w xPalacios et al. 7 used autoradiographic methods to
examine the A receptor in guinea-pig kidney. They1
observed that A receptors have a highly heteroge-1
neous distribution. More recently, the cDNAs encod-
w xing A and A receptors have been cloned 8–101 2
and used to identify and localize adenosine receptors
w xin the rat kidney 11 . A receptor is more abundant1
in collecting duct.
Adenosine regulates several renal functions, among
them the transport of solutes. Coulson and coworkers
w x12 found that adenosine increases the transport of
phosphate and glucose in opossum kidney cells.
w xTakeda and coworkers 13 showed that adenosine
stimulates the Naq-3HCOy cotransport in rabbit3
proximal convoluted tubule via an A -receptor-medi-1
ated mechanism. Furthermore, it has been reported
that A antagonists, such as DPCPX and FK-453,1
have diuretic and natriuretic action without affecting
 .the glomerular flow rate GFR and renal blood flow
 . w xRBF 14,15 . These effects were related to changes
in proximal tubule transport of ions.
Two sodium pumps have been described in kid-
 .  qney: 1 The classic ouabain-sensitive Na q
q.  .K ATPase and 2 the ouabain-insensitive,
furosemide-sensitive Naq-ATPase. The furosemide-
sensitive Naq-ATPase is found in a variety of tissues
from different animals including rat proximal tubule
w x q q16–18 . The Na -ATPase transports Na against an
electrochemical gradient and is not stimulated by Kq
w x19,20 . This pump has a widespread and parallel
 q q.distribution with the Na qK ATPase, and its in-
volvement in cell volume regulation has been pro-
w xposed 16,18,20,21 .
Since adenosine regulates the proximal sodium
transport it is possible that it modulates the sodium
pumps. In this work, we studied the effect of adeno-
sine on both the ouabain-insensitive Naq-ATPase and
 q q.the ouabain-sensitive Na qK ATPase activities
and their signaling pathway. We observed that adeno-
 q q.sine does not change the Na qK ATPase activity
but inhibits the furosemide-sensitive Naq-ATPase ac-
tivity via an A -receptor-mediated mechanism.1
2. Materials and methods
2.1. Materials
ATP, ouabain, furosemide, oligomycin, EGTA,
mannitol, pertussis toxin, cholera toxin, dibutyryl-
cAMP, peptide Thr–Thr–Tyr–Ala–Asp–Phe–Ile–
Ala–Ser–Gly–Arg–Thr–Gly–Arg–Arg–Asn–Ala–
.  .Ile–His–Asp inhibitor of protein kinase A PKAi
and adenosine were purchased from Sigma. N 6-
 . Xcyclohexyladenosine CHA and 5 -N-ethylcarbox-
 .amideadenosine NECA were purchased from Re-
search Biochemicals International; Percoll was from
Pharmacia. All chemical reagents were of the highest
w32 xpurity available. Pi Pi was obtained from the Insti-
tute of Energetic and Nuclear Research, Brazil.
All solutions were prepared with deionized glass-
w 32 xdistilled water. g- P ATP was prepared as de-
w xscribed by Maia and coworkers 22 .
2.2. Preparation of purified basolateral membrane
˝esicles
Basolateral membranes from pig kidney proximal
tubule cells were isolated from renal cortex by the
w xPercoll gradient method 23 modified from that de-
w x w xscribed by Scalera et al. 24 and Sacktor et al. 25 .
The membrane preparation was resuspended in 250
mM sucrose at a final concentration of 20–30 mg
protein mly1.
2.3. Measurement of ATPase acti˝ity
Except as noted under Section 3, the composition
 .of the standard assay medium 0.2 ml contained: 10
w 32 xmM MgCl ; 5 mM g- P ATP; 20 mM Hepes–Tris2
 . y1pH 7.0 ; 2 mg ml oligomycin; 1 mM EGTA plus
6 mM NaCl for measurement of the Naq-ATPase
activity or 90 mM NaCl and 20 mM KCl for mea-
 q q.surement of the Na qK ATPase activity. The
final osmolality was adjusted with mannitol to 300
mOsm kgy1.
The ATPase activity was measured according to
the method described by Grubmeyer and Penefsky
w x26 . The reaction was started by the addition of
vesicles to a final protein concentration of 0.3–0.5
mg mly1. The reaction was stopped after 40 min by
 .the addition of charcoal activated by HCl 0.1 N .
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w32 xThe P Pi released was measured in an aliquot of
the supernatant obtained after centrifugation of the
charcoal suspension for 20 min at 3000 rpm. Sponta-
w 32 xneous hydrolysis of g- P ATP was measured simul-
taneously in tubes where protein was added after the
acid. The Naq-ATPase activity was calculated by the
w32 xdifference between the P Pi released in the ab-
sence and in the presence of 2 mM furosemide, both
w x  qin the presence of 1 mM ouabain 27,28 . The Na
q.qK ATPase activity was calculated by the differ-
w32 xence between the P Pi released in the absence and
w xin the presence of 1 mM ouabain 29 . The averages
of the control values were 8.63"1.80 and 73.01"
7.89 nmol 32Pi mgy1 miny1 for ouabain-insensitive
q  qNa -ATPase and ouabain-sensitive Na q
q.K ATPase activities, respectively. The incubation
time of the protein with the reagents is the same as
for the reaction. Protein concentrations were deter-
w xmined using the Folin phenol reagent 30 and bovine
serum albumin as a standard. Different preparations
of basolateral vesicles were used for each experiment.
The data were analyzed by two-way analysis of
 .variance ANOVA , considering the treatments as
factors. The significance of the differences was veri-
fied by the Bonferroni t-test. Statistical analysis was
made using absolute values and the results were
expressed in percentage of the control.
3. Results
( q q)3.1. Effect of adenosine on the Na qK ATPase
and Naq-ATPase acti˝ities
It has been observed that adenosine regulates sev-
w xeral ion transport systems 12 . Recently, it was ob-
served that adenosine regulates the Naq-3HCOy co-3
transport in rabbit proximal convoluted tubule via A1
w xreceptors 13 . To determine whether exogenous
adenosine regulates the two sodium pumps present in
basolateral membrane from proximal tubule, we mea-
sured both the sodium-stimulated ouabain-sensitive
ATPase activity and the sodium stimulated ouabain-
insensitive furosemide-sensitive ATPase activity in
the absence or in the presence of different adenosine
 y3 y10 .concentrations from 10 to 10 M . The results
are shown in Fig. 1. The dependence on adenosine
concentrations of the furosemide-sensitive ATPase
q  .Fig. 1. Dependence of ouabain-insensitive Na -ATPase v and
 q q.  .ouabain-sensitive Na qK ATPase ’ activities on adeno-
sine concentration. The ATPase activity was measured as de-
 .scribed in Section 2 ns10 . The adenosine concentration was
increased from 10y10 up to 10y3 M. Results are expressed as
percentage of the control.
 .activity showed a biphasic behavior Fig. 1 . Initially,
the increase in adenosine concentration decreased the
furosemide-sensitive ATPase activity by 56% P-
. y80.05 , with maximal inhibition at 10 M adenosine.
Further increase in the concentration of adenosine
abolished this inhibition, and complete reversal was
obtained at a concentration of 10y3 M. In contrast,
the increase in adenosine concentration did not affect
 q q.the ouabain-sensitive Na q K ATPase activity
 .Fig. 1 .
3.2. Adenosine receptor agonists and antagonists
Since P receptor is sensitive to methylxanthines1
such as theophylline and P receptor is not, this2
antagonist was used to clarify the receptor type in-
w xvolved in the adenosine effect 1 . Fig. 2 shows the
modulation of the adenosine effect on the
furosemide-sensitive ATPase activity by theo-
phylline. The increase in theophylline concentration
from 10y9 to 10y4 M reversed the inhibition pro-
moted by 10y8 M adenosine. The maximal effect
was obtained with 10y6 M theophylline. The addi-
tion of 10y6 M theophylline alone did not change
significantly the ATPase activity 14.1"13.2%, P)
.0.05 .
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Fig. 2. Modulation of the effect of adenosine on ouabain-insensi-
q  .tive Na -ATPase activity by theophylline Theo . The ATPase
 .activity was measured as described in Section 2 ns9 . The
theophylline concentration was increased from 10y9 up to 10y4
y8  . aM. 10 M adenosine Ade was added where indicated. Statis-
 . btically significant when compared to control P -0.05 . Statis-
tically significant when compared to the level of the ATPase
y8  .activity in the presence of 10 M adenosine P -0.05 . Results
are expressed as percentage of the control.
The P receptor can be subdivided into A and A1 1 2
w xreceptors 5 . These receptors can be activated by
different agonists. The adenosine analog N 6-
 .cyclohexyladenosine CHA has higher affinity for
A receptor while 5X-N-ethyl-carboxamide adenosine1
 .NECA has higher affinity for the A receptor2
w x5,31,32 .
Fig. 3 shows the effect of an increase in CHA
concentration from 10y11 to 10y6 M, on the Naq-
 q q.ATPase and Na qK ATPase activities. The in-
crease of CHA concentration up to 10y8 M de-
creased the Naq-ATPase activity in 56%. Further
increase in CHA concentration increased the enzyme
activity. Similarly to adenosine, CHA did not change
 q q.the Na qK ATPase activity.
The increase of NECA concentration from 10y8 to
10y5 M did not change the Naq-ATPase activity
 . y6Fig. 4 . Similarly, the addition of 10 M NECA
 q q.did not modify the Na qK ATPase activity as
shown in the inset of Fig. 4.
q  .Fig. 3. Dependence of ouabain-insensitive Na -ATPase v and
 q q.  .ouabain-sensitive Na qK ATPase ’ activities on CHA
concentration. The ATPase activity was measured as described in
 .Section 2 ns7 . The CHA concentration was increased from
10y11 up to 10y6 M. a Statistically significant when compared
 .to control P -0.05 . Results are expressed as percentage of the
control.
Fig. 4. Dependence of ouabain-insensitive Naq-ATPase and
 q q.  .ouabain-sensitive Na qK ATPase activities inset on NECA
concentration. The ATPase activity was measured as described in
 .Section 2 ns7 . The NECA concentration was increased from
10y8 up to 10y5 M. The conditions of the experiments shown in
the inset were described in Section 2. Results are expressed as
percentage of the control.
( )C. Caruso-Ne˝es et al.rBiochimica et Biophysica Acta 1329 1997 336–344340
3.3. G-protein in˝ol˝ement
It has been described that A receptors are coupled1
to pertussis toxin-sensitive GTP binding protein Gi
. w xprotein 1,4,5 . Thus, if the adenosine effect on the
furosemide-sensitive ATPase activity is mediated by
activation of the Gi protein, addition of pertussis
toxin, an inhibitor of Gi protein, should reverse the
effect of adenosine. Addition of 1 mg mly1 pertussis
toxin completely reversed the inhibition of the
furosemide-sensitive ATPase activity by adenosine
 .Fig. 5 . The addition of pertussis toxin alone did not
affect the furosemide-sensitive ATPase activity.
Addition of 10y9 M cholera toxin alone, a Gs
protein stimulator, increased the Naq-ATPase activity
by 60%. When 10y8 M adenosine was added simul-
taneously with cholera toxin, the furosemide-sensitive
 .ATPase activity was decreased 42% P)0.05 , when
compared to the level obtained with cholera toxin
 .alone Fig. 6 .
3.4. cAMP in˝ol˝ement
The data obtained so far suggest that the effect of
adenosine involves the activation of Gi protein. So, if
Fig. 5. Inhibition of the effect of adenosine on ouabain-insensi-
q y1 tive Na -ATPase activity by 1 mg ml Pertussis toxin Per.
.Tx. . The ATPase activity was measured as described in Section
 . y8  .2 ns10 . 10 M adenosine Ade was added where indicated.
a  .Statistically significant when compared to control P -0.05 .
Results are expressed as percentage of the control.
Fig. 6. Modulation of the effect of adenosine on ouabain-insensi-
q  .tive Na -ATPase activity by 1 nM Cholera toxin Chol. Tx. .
The ATPase activity was measured as described in Section 2
 . y8  .ns10 . 10 M adenosine Ade was added where indicated.
a  .Statistically significant when compared to control P -0.05 .
Results are expressed as percentage of the control.
Fig. 7. Reversal of the effect of adenosine on ouabain-insensitive
Naq-ATPase activity by increasing dibutyryl-AMPc concentra-
tion. The ATPase activity was measured as described in Section 2
 . y8  .ns10 . 10 M adenosine Ade was added where indicated.
a  .Statistically significant when compared to control P -0.05 .
b Statistically significant when compared to the level of the
y8  .ATPase activity in the presence of 10 M adenosine P -0.05 .
Results are expressed as percentage of the control.
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Fig. 8. Modulation of the effect of adenosine on ouabain-insensi-
tive Naq-ATPase activity by addition of 10 nM protein kinase A
 .inhibitor PKAI . The ATPase activity was measured as de-
 . y8  .scribed in Section 2 ns10 . 10 M adenosine Ade was
added where indicated. a Statistically significant when compared
 .to control P -0.05 . Results are expressed as percentage of the
control.
the Gi protein decreases the adenylyl cyclase activity
it is possible that an increase in the cAMP level
reverses the inhibition promoted by adenosine. Fig. 7
shows that an increase in dibutyryl-cAMP, permeant
analog of cAMP, concentration from 10 to 500 mM
increased the furosemide-sensitive ATPase activity in
the presence of adenosine. Complete reversal of the
adenosine inhibition of the furosemide-sensitive AT-
Pase activity was obtained at 2=10y4 M dibutyryl-
cAMP. The same results were obtained with 10y4 M
cAMP indicating that the site of action of cAMP is
 .located on the outside of the vesicle data not shown .
However, we can not rule out the presence of leaky
vesicles. The addition of 10y4 M cAMP alone did
not change significantly the ATPase activity 2.7"
.2.0%, P)0.05 .
cAMP effects are mediated through the activation
of protein kinase A. If the effect of adenosine is
related to a decrease in cAMP levels, protein kinase
A activity should be decreased. To determine if
protein kinase A is involved in adenosine inhibition
of Naq-ATPase activity, we carried out experiments
using the protein kinase A inhibitor peptide alone
 .Fig. 8 . Addition of 200 nM protein kinase A in-
hibitor peptide inhibited the furosemide-sensitive
Naq-ATPase activity by 50%. The simultaneous addi-
tion of adenosine and protein kinase A inhibitor
peptide were not additive.
4. Discussion
In the present work, we studied the regulation of
 q q.the ouabain-sensitive Na qK ATPase activity and
ouabain-insensitive, furosemide-sensitive Naq-
w xATPase activity by adenosine. Proverbio et al. 33
described two forms of Naq-stimulated ATPase activ-
ity which were present in aged microsomal fractions
from guinea-pig kidney cortex. One was the well
 q q.known ouabain-sensitive Na q K ATPase, the
other was ouabain-insensitive, Naq-stimulated AT-
Pase activity which was preferentially sensitive to
ethacrynic acid and furosemide. Proverbio and Del
w xCastillo 34 showed that the ouabain-insensitive
Naq-stimulated ATPase is present in basolateral
membranes of proximal tubular cells of guinea-pigs.
Several papers have shown the differences between
 q q.ouabain-sensitive Na qK ATPase and ouabain-
insensitive, furosemide-sensitive Naq-ATPase
w x16,18–20,27,35,36 .
Recently, it was reported that the highly selective
A receptor antagonists FK-453 and DPCPX have1
diuretic and natriuretic action, although these com-
pounds induced little or no increase in renal plasma
w xflow and glomerular filtration rate 14,15 . FK-453
also increases urinary excretion of phosphate and
y w xHCO in humans in addition to natriuresis 14 .3
w xTakeda and coworkers 13 showed that FK-453 in-
hibited the Naq-HCOy cotransporter in rabbit convo-3
lute proximal tubule.
w xAdenosine has multiple actions in the kidney 4,6 .
In this paper, we show that adenosine inhibits the
furosemide-sensitive Naq-ATPase activity in concen-
trations as low as 5=10y8 M. When the adenosine
concentration was increased to 10y3 M the inhibitory
effect was reversed. These data suggest that adeno-
sine binds to different sites but more experiments are
needed to elucidate this observation. In the present
work, we studied only the inhibitory effect of adeno-
sine. Adenosine is a normal constituent of all body
w xfluids including the extracellular space 37–39 . It
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has been calculated that the total renal adenosine
concentration is 7 mM in rats and 9.5 mM in dogs
w x40 , whereas the extracellular concentration ranges
w xfrom 0.1 to 1 mM 14 . Furthermore, it was observed
that adenosine concentration increases several fold in
w xspecial situations such as ischemia 41 . We observed
that the maximal effect of adenosine on furosemide-
sensitive ATPase activity was obtained at 10y8 M.
Therefore, the effects of adenosine observed in this
work may be of potential significance in vivo.
The inhibitory effect of adenosine on the
furosemide-sensitive Naq-ATPase activity is medi-
ated by the P type adenosine receptor. This is sup-1
ported by the observation that the effect of adenosine
 .is abolished by addition of theophylline Fig. 2 .
Methylxanthines, such as theophylline, are antago-
w xnists of the P -receptor but not of P receptors 5 .1 2
The P -receptor is subdivided into A and A recep-1 1 2
w x w xtors 5 which are both present in the kidney 11 . In
addition, it has also been shown that adenosine regu-
lates the Naq-3HCOy cotransport in rabbit proximal3
w xconvoluted tubules via A receptors 13 . The affini-1
ties of A and A receptors for adenosine are 0.5–1001 2
w xnM and 0.5–25 mM, respectively 5 . Fig. 1 shows
that the adenosine concentration that inhibits the
Naq-ATPase activity is close to the adenosine con-
centration that binds to the A receptor, suggesting1
that the effect of adenosine could be mediated by the
A receptor. This hypothesis is favored by the obser-1
vation that adenosine analogues with higher affinity
for A receptor such as N 6-cyclohexyladenosine1
 . qCHA inhibit the Na -ATPase activity at low con-
 .centrations Fig. 3 . Furthermore, the addition of
X  .5 -N-ethylcarboxamideadenosine NECA , a selective
agonist for the A receptor, did not change neither2
q  q q.Na -ATPase activity nor Na qK ATPase activity
 .Fig. 4 . In some tissues it has been described that A1
and A receptors have the same affinity for NECA.2
The absence of effect of NECA on the Naq-ATPase
could be due the simultaneous interaction of NECA
with both A and A receptors. Taken together, these1 2
data indicate that adenosine inhibits Naq-ATPase
activity through its interaction with the A -subtype of1
adenosine receptor. However, the observation that
 y7high concentrations of adenosine and CHA )10
. qM promotes an increase is Na -ATPase activity
when compared to that obtained in presence of 10y8
 .M adenosine or CHA Figs. 1 and 3 suggests that the
binding of adenosine to A receptors modulates2
Naq-ATPase activity.
All subtypes of adenosine receptors belong to the
family of rhodopsin-like G protein-coupled receptors
w x1,5,39 . The A receptor couples to members of the1
pertussis toxin-sensitive GTP binding protein family
w x5 . These G proteins may inhibit adenylyl cyclase.
Our results suggest that the pertussis toxin-sensitive
GTP binding protein inhibitory G protein; Gi pro-
. qtein is involved in adenosine inhibition of the Na -
ATPase activity. This is supported by the observation
that the effect of adenosine is reversed by addition of
 .pertussis toxin, an inhibitor of Gi protein Fig. 5 .
The different levels observed with adenosine plus
cholera toxin and adenosine alone could be explained
because cholera toxin per se stimulated the ATPase
activity. Probably this effect is not correlated to
stimulation of the cAMP cascade since the addition
of 5=10y4 M cAMP plus 10y8 M adenosine did
 .not change the ATPase activity Fig. 7 . We then
propose that the cholera toxin and adenosine modu-
late the Naq-ATPase activity by different, non-inter-
active ways, suggesting that Gs protein is not in-
volved in the effect of adenosine on the Naq-ATPase
activity.
If the effect of adenosine on Naq-ATPase activity
is due to a decreased adenylyl cyclase activity, the
addition of dibutyryl-cAMP should reverse this inhi-
bition. In Fig. 7, we show that increasing dibutyryl-
cAMP concentration completely reverses the effect of
adenosine on the Naq-ATPase activity. The reversal
of the effect of adenosine by cAMP has been ob-
served in different systems from different prepara-
w xtions 4,13,42,43 .
cAMP effects are described as being mediated by
stimulation of protein kinase A which in turn pro-
motes phosphorylation of specific substrates. Thus, it
is possible that inhibition of Naq-ATPase activity by
adenosine could be due to inhibition of protein kinase
A. This hypothesis is supported by the observation
that the addition of the specific inhibitor peptide of
protein kinase A had an effect on the Naq-ATPase
activity similar to that of adenosine.
The possible role for furosemide-sensitive Naq-
w xATPase is unknown. Borgatti and coworkers 21
proposed a widespread and parallel distribution of the
furosemide-sensitive Naq-ATPase and ouabain-sensi-
 q q. w xtive Na qK ATPase. Moretti and coworkers 16
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showed that the furosemide-sensitive Naq-ATPase
was found in a variety of tissues from different
animals and is activated by hyposmotic shock and
inhibited by hyperosmotic shock. It has been pro-
posed that the furosemide-sensitive Naq-ATPase may
be involved in the extrusion of Naq from the intra-
cellular compartment in order to decrease its osmolal-
ity and regulate the cellular volume in hyposmotic
w xmedium 16,18,20 . Thus, it is possible that adenosine
is involved in cell volume regulation of the proximal
tubule during hyperosmotic shock by regulation of
the furosemide-sensitive Naq-ATPase. On the other
hand, the possible involvement of furosemide-sensi-
tive Naq-ATPase in proximal tubule sodium reab-
sorption cannot be discarded, which is compatible
with the adenosine effect on sodium excretion de-
w xscribed by several workers 14,15,36 .
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